Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
15 July 2021 | Story Lunga Luthuli

The Three-Minute Thesis Competition, also known as the ‘3MT’, is an annual competition held at 200 universities around the world. It is open to PhD and master’s students, challenging participants to present their research in just 180 seconds – in a way that is understood by an audience with no background in the research area.

Click here for more information

The competition originated at the University of Queensland, Australia. The UFS Postgraduate School was the first to bring the ‘Three-Minute Thesis’ (3MT) competition to Africa, and it has now become an annual event at the UFS.

The competition aims to assist participants in the development of presentation, research, and academic communication skills, as well as to support the development of research students.

Each faculty will run the 3MT at faculty level. Winners from each faculty will compete against each other during the institutional competition on 1 October 2021 and will stand a chance to win these awesome cash prizes.

UFS INSTITUTIONAL PRIZES FOR 2021 ARE:

Position Prizes 2021
Master’s winner R6 000
Master’s 1st runner-up R4 000
Master’s 2nd runner-up R2 000
PhD winner  R8 000
PhD 1st runner-up R6 000
PhD 2nd runner-up R4 000


Winners of the institutional competition will go ahead to compete against other universities on 29 October 2021.

 


News Archive

Newly operational sequencing unit in genomics at UFS
2016-09-09

Description: Next Generation Sequencing  Tags: Next Generation Sequencing

Dr Martin Nyaga and his research assistant,
Tshidiso Mogotsi in the Next Generation
Sequencing Laboratory.
Photo: Charl Devenish

The Next Generation Sequencing (NGS) unit at the UFS was established as an interdisciplinary facility under the Directorate for Research Development, Faculty of Health Sciences and Faculty of Natural and Agricultural Sciences.

The aim of the NGS facility is to aid internal and external investigators undertaking studies on Deoxyribonucleic acid (DNA) sequencing, assembly and bioinformatics approaches using the more advanced Illumina MiSeq NGS platform.

The NGS unit became operational in 2016 and is managed by Dr Martin Nyaga and administered through the office of the Dean, Faculty of Health Sciences, under the leadership of Prof Gert Van Zyl. Dr Nyaga has vast experience in microbial genomics, having done his PhD in Molecular Virology.

He has worked and collaborated with globally recognised centres of excellence in Prokaryotic and Eukaryotic genomics, namely the J. Craig Venter Institute and the Laboratory of Viral Metagenomics, Rega Institute, among others.

The unit has undertaken several projects and successfully generated data on bacterial, viral and human genomes. Currently, work is ongoing on bacterial and fungal metagenomics studies through 16S rRNA sequencing.

In addition, the unit is also working on plasmid/insert sequencing and whole genome sequencing of animal and human rotaviruses. The unit has capacity to undertake other kinds of panels like the HLA, Pan-cancer and Tumor 15 sequencing, among others.

Several investigators from the UFS including but not limited to Prof Felicity Burt, Prof Wijnand Swart, Dr Frans O’Neil, Dr Trudi O'Neill, Dr Charlotte Boucher, Dr Marieka Gryzenhout and Dr Kamaldeen Baba are actively in collaboration with the NGS unit.

The unit has also invested in other specialised equipment such as the M220 Focused-ultrasonicator (Covaris), 2100 Bioanalyzer system (Agilent) and the real-time PCR cycler, the Rotor-Gene Q (Qiagen), which both the UFS and external investigators can use for their research.

Investigators working on molecular and related studies are encouraged to engage with Dr Nyaga on how they would like to approach their genomics projects at the UFS NGS unit. 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept